Additionally, by deleting Jnk3 in the type II SMA pups, the authors observed a significant reduction of neurodegeneration, a partial systemic rescue of SMA phenotype, improved motor functions, and increased lifespan of SMA mice (Genabai et al., 2015). This evidence concerns the gene MAPK10 and proximal spinal muscular atrophy.